30.04.2018 • NewsbiologicsCatalentPharmaceuticals

Catalent Biologics Restructures Biologics Business

Tedd Green, former president of Cook Pharmica, has been appointed as senior...
Tedd Green, former president of Cook Pharmica, has been appointed as senior vice president of Catalent Biologics.

US drugmaker Catalent announced key organizational changes within its biologics business.

Tedd Green, former president of Cook Pharmica, has been appointed as senior vice president of Catalent Biologics, and will have responsibility for the entire biologics business. In this role he will also act as a member of Catalent’s executive leadership team. Green will be based at the Bloomington facility.

Mike Riley has been appointed as vice president and general manager of Drug Substance and Bioanalytical services for Catalent Biologics. He will lead the company’s biologics manufacturing business based at several sites across Catalent’s global network.

Cory Lewis will take on the new role of vice president and general manager of the company’s Drug Product business, with a focus on growing the drug product offerings both in the US and in Europe.

In a further move, Ryan Hawkins has been appointed as general manager of the Bloomington site.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.